Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 -- Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary...

Related Keywords

Boston ,Massachusetts ,United States ,New York ,American ,Dan Budwick ,Danielle Keatley ,Equity Syndicate Prospectus Department ,Morgan Stanley Co ,Syndicate Department ,Equity Syndicate Department ,Structure Therapeutics Inc ,Guggenheim Securities ,Exchange Commission ,Capital Markets Corp ,Morgan Stanley ,Prospectus Department ,Nasdaq ,Goldman Sachs Co ,Structure Therapeutics ,Leerink Partners ,Markets Corp ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,